Ana Malovrh, publicly known as Ana in Style, is the founder of Choose Your Signature Style™. As a dynamic and innovative Style Metamorph, she specializes in helping high-profile women leaders align their personal and professional images for greater success, confidence, and impact. 

Ana's journey began with a deep understanding of the power of nonverbal communication, transforming her own life and leading her to become a Certified Virtual Personal Stylist and Visual Brand Consultant.

As a Manifesting Generator, Ana brings a unique, multifaceted approach to her work, ensuring dynamic and meaningful transformations. She is also a passionate advocate for sustainable fashion, integrating eco-friendly practices into her styling philosophy.

Outside the public eye, she is a loving and patient special needs mom. Ana's insights on personal styling and visual branding have been featured in Brainz, Feminessence, and other magazines, and she is a sought-after podcast guest. She shares her expertise on topics such as the impact of visual appearance on professional success, the role of colors in enhancing confidence and well-being, and strategies for creating a cohesive personal image.

As a speaker, Ana creates a thought-provoking atmosphere with her philosophical approach to personal appearance, the impact and meaning of colors, and the dynamics of relationships, including self-relationship. Her fresh perspectives often leave audiences with new insights, commonly hearing, "You made me think, I never thought of it that way."

Recognized as a specialized expert, Ana has been invited to join several groups of highly skilled professionals. Through her extensive studies on verbal and non-verbal communication, she has developed innovative methodologies that help individuals manage their states of mind and being through their physical appearance.

Ana is committed to giving back, supporting charity projects aimed at children on three continents: Europe, South America, and Africa. She also supports research on neurological disorders and the development of novel treatments for intellectual disability in rare syndromes.